![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiBeWct9FeTk0x7iWOzTJptNv3XuRMB_6pq09MnAZhv1-7biLrkF-cMEyTJ7v1Vwl4mN2SSudhfd2_Cxv5cyE0CWXtEIjtVkbW-gzIzc1qZ7223HSm1DKj68uT3SV4zOTp76WbDZ48NHlk/s16000-rw/walmart-store-exterior-at-night.jpg)
ReliOn™ NovoLog® is a rapid-acting insulin analog used to control high blood sugar in adults and children with diabetes.
![]() |
NovoLog ReliOn Box and Vial |
Notably, 25% of insulin users skip doses due to high prices and Walmart claims that its new offering ---analog insulin vials ($72.88) and FlexPen® ($85.88) --- will save customers1 between 58% to 75% off the cash price of branded analog insulin products, which translates to a savings of up to $101 per branded vial or $251 per package of branded FlexPens®. Walmart’s more affordable option could win new customers to its healthcare business.
And, of course customers will need a prescription in order to purchase the these insulin products.
Walmart has just begun to play a major role in affordable healthcare with plans to open 4,000 health clinics by 2029. Its prescription program offers a monthly supply of drugs for $4 to compete with Amazon Pharmacy. As more players like Walmart enter the retail healthcare space, increased competition could drive down the costs of generic medicine.
And, of course customers will need a prescription in order to purchase the these insulin products.
Walmart has just begun to play a major role in affordable healthcare with plans to open 4,000 health clinics by 2029. Its prescription program offers a monthly supply of drugs for $4 to compete with Amazon Pharmacy. As more players like Walmart enter the retail healthcare space, increased competition could drive down the costs of generic medicine.
Advertisements